PortfoliosLab logoPortfoliosLab logo
IBB vs. ACWI
Performance
Return for Risk
Drawdowns
Volatility
Dividends

Performance

IBB vs. ACWI - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in iShares Nasdaq Biotechnology ETF (IBB) and iShares MSCI ACWI ETF (ACWI). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, IBB achieves a -0.68% return, which is significantly lower than ACWI's 12.13% return. Over the past 10 years, IBB has underperformed ACWI with an annualized return of 6.23%, while ACWI has yielded a comparatively higher 12.85% annualized return.


IBB

1D
1.97%
1M
-1.56%
YTD
-0.68%
6M
-2.57%
1Y
34.50%
3Y*
9.40%
5Y*
2.10%
10Y*
6.23%

ACWI

1D
-0.83%
1M
5.28%
YTD
12.13%
6M
12.96%
1Y
29.18%
3Y*
21.15%
5Y*
11.28%
10Y*
12.85%
*Multi-year figures are annualized to reflect compound growth (CAGR)

IBB vs. ACWI - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
IBB
iShares Nasdaq Biotechnology ETF
-0.68%27.98%-2.41%3.76%-13.69%0.95%26.01%25.42%-9.53%21.08%
ACWI
iShares MSCI ACWI ETF
12.13%22.41%17.45%22.27%-18.39%18.66%16.34%26.59%-9.19%24.33%

Correlation

The correlation between IBB and ACWI is 0.54, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.54

Correlation (3Y)
Calculated over the trailing 3-year period

0.60

Correlation (5Y)
Calculated over the trailing 5-year period

0.64

Correlation (10Y)
Calculated over the trailing 10-year period

0.63

Correlation (All Time)
Calculated using the full available price history since Mar 31, 2008

0.63

The correlation between IBB and ACWI shifts across timeframes, from 0.54 (1 year) to 0.64 (5 years), reflecting how their relationship changes across market environments.

IBB vs. ACWI - Sectors Allocation Comparison


Sectors
IBB
ACWI

Healthcare

100.0%
8.1%

Basic Materials

-

3.7%

Communication Services

-

9.0%

Consumer Cyclical

-

9.3%

Consumer Defensive

-

5.0%

Energy

-

4.2%

Financial Services

-

16.1%

Industrials

-

10.9%

Real Estate

-

1.8%

Technology

-

29.4%

Utilities

-

2.6%

Healthcare

IBB
100.0%
ACWI
8.1%

Basic Materials

IBB

-

ACWI
3.7%

Communication Services

IBB

-

ACWI
9.0%

Consumer Cyclical

IBB

-

ACWI
9.3%

Consumer Defensive

IBB

-

ACWI
5.0%

Energy

IBB

-

ACWI
4.2%

Financial Services

IBB

-

ACWI
16.1%

Industrials

IBB

-

ACWI
10.9%

Real Estate

IBB

-

ACWI
1.8%

Technology

IBB

-

ACWI
29.4%

Utilities

IBB

-

ACWI
2.6%

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

IBB vs. ACWI — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

IBB
IBB Risk / Return Rank: 5656
Overall Rank
IBB Sharpe Ratio Rank: 5050
Sharpe Ratio Rank
IBB Sortino Ratio Rank: 5050
Sortino Ratio Rank
IBB Omega Ratio Rank: 4646
Omega Ratio Rank
IBB Calmar Ratio Rank: 7171
Calmar Ratio Rank
IBB Martin Ratio Rank: 6262
Martin Ratio Rank

ACWI
ACWI Risk / Return Rank: 6666
Overall Rank
ACWI Sharpe Ratio Rank: 6868
Sharpe Ratio Rank
ACWI Sortino Ratio Rank: 6767
Sortino Ratio Rank
ACWI Omega Ratio Rank: 6767
Omega Ratio Rank
ACWI Calmar Ratio Rank: 5959
Calmar Ratio Rank
ACWI Martin Ratio Rank: 7171
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

IBB vs. ACWI - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for iShares Nasdaq Biotechnology ETF (IBB) and iShares MSCI ACWI ETF (ACWI). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


IBBACWIDifference

Sharpe ratio

Return per unit of total volatility

1.74

2.29

-0.55

Sortino ratio

Return per unit of downside risk

2.50

3.17

-0.66

Omega ratio

Gain probability vs. loss probability

1.30

1.41

-0.12

Calmar ratio

Return relative to maximum drawdown

3.60

3.01

+0.59

Martin ratio

Return relative to average drawdown

11.43

13.53

-2.10

IBB vs. ACWI - Sharpe Ratio Comparison

The current IBB Sharpe Ratio is 1.74, which is comparable to the ACWI Sharpe Ratio of 2.29. The chart below compares the historical Sharpe Ratios of IBB and ACWI, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


IBBACWIDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

1.74

2.29

-0.55

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

0.10

0.71

-0.61

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.27

0.75

-0.48

Sharpe Ratio (All Time)

Calculated using the full available price history

0.26

0.43

-0.17

Drawdowns

IBB vs. ACWI - Drawdown Comparison

The maximum IBB drawdown since its inception was -62.85%, which is greater than ACWI's maximum drawdown of -56.00%. Use the drawdown chart below to compare losses from any high point for IBB and ACWI.


Loading charts...

Drawdown Indicators


IBBACWIDifference

Max Drawdown

Largest peak-to-trough decline

-62.85%

-56.00%

-6.85%

Max Drawdown (1Y)

Largest decline over 1 year

-9.63%

-9.73%

+0.10%

Max Drawdown (3Y)

Largest decline over 3 years

-24.85%

-16.55%

-8.30%

Max Drawdown (5Y)

Largest decline over 5 years

-39.82%

-26.42%

-13.40%

Max Drawdown (10Y)

Largest decline over 10 years

-39.82%

-33.53%

-6.29%

Current Drawdown

Current decline from peak

-5.64%

-0.83%

-4.81%

Average Drawdown

Average peak-to-trough decline

-21.18%

-8.61%

-12.57%

Ulcer Index

Depth and duration of drawdowns from previous peaks

3.03%

2.16%

+0.87%

Volatility

IBB vs. ACWI - Volatility Comparison

iShares Nasdaq Biotechnology ETF (IBB) has a higher volatility of 6.86% compared to iShares MSCI ACWI ETF (ACWI) at 3.93%. This indicates that IBB's price experiences larger fluctuations and is considered to be riskier than ACWI based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


IBBACWIDifference

Volatility (1M)

Calculated over the trailing 1-month period

6.86%

3.93%

+2.93%

Volatility (6M)

Calculated over the trailing 6-month period

15.38%

10.29%

+5.09%

Volatility (1Y)

Calculated over the trailing 1-year period

19.89%

12.78%

+7.11%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

21.99%

16.05%

+5.94%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

23.22%

17.11%

+6.11%

IBB vs. ACWI - Expense Ratio Comparison

IBB has a 0.47% expense ratio, which is higher than ACWI's 0.32% expense ratio.


Dividends

IBB vs. ACWI - Dividend Comparison

IBB's dividend yield for the trailing twelve months is around 0.23%, less than ACWI's 1.38% yield.


PositionTTM20252024202320222021202020192018201720162015
ACWI
iShares MSCI ACWI ETF
1.38%1.55%1.70%1.88%1.79%1.71%1.43%2.33%2.18%1.94%2.19%2.56%
IBB
iShares Nasdaq Biotechnology ETF
0.23%0.23%0.29%0.26%0.31%0.21%0.21%0.33%0.20%0.30%0.19%0.03%

Frequently Asked Questions


IBB and ACWI have a correlation of 0.54, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

IBB has higher volatility (6.86%) compared to ACWI (3.93%). In terms of maximum drawdown, IBB dropped -62.85% vs ACWI's -56.00%.

On 10-year performance, ACWI leads with 12.85% vs 6.23% for IBB. On fees, ACWI is cheaper at 0.32% per year. On volatility, ACWI has been the lower-risk option at 3.93%. The better choice depends on whether you care most about return, fees, risk, or income.

Over the 10-year period, ACWI has performed better with a 12.85% return vs 6.23%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.

ACWI is cheaper with a 0.32% expense ratio, compared with 0.47% for IBB.

ACWI has the higher dividend yield at 1.38%, compared with 0.23% for IBB.

IBB is categorized as Health & Biotech Equities, while ACWI is Global Equities. IBB tracks NASDAQ Biotechnology Index, while ACWI tracks MSCI All Country World Index. Their fees differ too: 0.47% for IBB and 0.32% for ACWI.

ACWI currently has the higher Sharpe Ratio (2.29 vs 1.74), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for IBB and ACWI

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer